Source: sec.gov

Bioarray: Bioarray Genetics, Inc. Received $5.2M in Equity Funding

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Founder & CEO

Marcia Fournier

CEO Approval Rating

71/100

Bioarray develops and commercializes breast cancer predictive molecular tests for the optimization of drug discovery and development.